Article Information
PubMed
Published By
History
- Received June 27, 2006
- Revision received June 28, 2006
- Accepted June 29, 2006
- First published August 2, 2006.
- Version of record published August 2, 2006.
Copyright & Usage
Copyright © 2006 Society for Neuroscience 0270-6474/06/268017-04$15.00/0
Author Information
Author contributions
Disclosures
- Received June 27, 2006.
- Revision received June 28, 2006.
- Accepted June 29, 2006.
-
Dr. Rhodes is an advisory board member and Dr. Trimmer is the Director of NeuroMab. NeuroMab is supported by National Institute of Neurological Disorders and Stroke/National Institute of Mental Health Grant U24NS50606. We thank Dr. Milena Menegola for images and helpful comments, Dr. Randy Stewart for helpful comments, and past and current colleagues for their invaluable contributions to antibody generation and characterization in our respective laboratories.
- Correspondence should be addressed to Dr. James S. Trimmer, Department of Pharmacology, School of Medicine, 3502 GBSF, University of California, One Shields Avenue, Davis, CA 95616. Email: jtrimmer{at}ucdavis.edu
Online Impact
Article usage
In this issue
Antibodies as Valuable Neuroscience Research Tools versus Reagents of Mass Distraction
